PRKN and ovarian cancer: We next investigated whether the canonical PINK1/Parkin pathway played a role in ovarian cancer development and chemoresistance, but low levels of Parkin in ovarian cancer were observed via sample data retrieved from The Human Protein Atlas (Fig. S4A).